Daily Cardiology Research Analysis
Analyzed 129 papers and selected 3 impactful papers.
Summary
Today’s top cardiology research spans interventional, diagnostic, and public health advances. Intravascular imaging (OCT/IVUS) guidance during PCI reduced major adverse cardiovascular events across complex lesions. An interpretable multicenter AI model integrating PET biomarkers improved obstructive CAD diagnosis, and simple electronic nudges substantially increased influenza vaccination uptake in younger and middle-aged adults with atrial fibrillation.
Research Themes
- Imaging-guided optimization of PCI in complex coronary disease
- Interpretable AI integrating multimodal PET biomarkers for CAD diagnosis
- Behavioral nudges to enhance vaccination uptake in high-risk cardiac populations
Selected Articles
1. IVUS, OCT, or Angiography as Guidance for PCI in Complex Coronary Artery Lesions: Network Meta-Analysis of Randomized Controlled Trials.
Across 17 RCTs with 13,751 patients, both OCT- and IVUS-guided PCI significantly reduced MACE versus angiography-only guidance in complex lesions, with consistent benefits across CTO, left main, bifurcation, multivessel, and calcified subsets. No significant difference was found between OCT and IVUS.
Impact: This synthesis of RCTs provides decisive, lesion-agnostic evidence favoring intravascular imaging guidance for PCI in complex coronary disease, directly informing procedural strategy.
Clinical Implications: For complex PCI, routine use of IVUS or OCT should be prioritized over angiography alone to reduce MACE. Choice between OCT and IVUS can be individualized, as outcomes were similar.
Key Findings
- Intravascular imaging guidance reduced MACE versus angiography-only PCI in complex lesions (OCT RR 0.63; IVUS RR 0.67).
- Benefits were consistent across CTO, left main, bifurcation, multivessel, and calcified lesions.
- No significant difference in MACE between OCT and IVUS guidance.
Methodological Strengths
- Lesion-level network meta-analysis restricted to randomized controlled trials
- Consistent findings across multiple complex lesion subgroups using random-effects modeling
Limitations
- Indirect comparisons inherent to network meta-analysis
- Heterogeneity in trial protocols, imaging criteria, and operator experience
Future Directions: Head-to-head OCT vs IVUS RCTs focused on complex subsets, cost-effectiveness analyses, and implementation studies to optimize uptake in diverse practice settings.
BACKGROUND: Intravascular imaging-guided percutaneous coronary intervention (PCI) reduces cardiovascular events compared with angiography-guided PCI alone. However, there is a paucity of data comparing these approaches in patients with complex coronary artery lesions and their respective subgroups. OBJECTIVES: The aim of this study was to assess the impact of intravascular ultrasound (IVUS)-guided and optical coherence tomography (OCT)-guided PCI on reducing major adverse cardiovascular events (MACE) compared with angiography-guided PCI in different complex lesions subsets. METHODS: In this lesion-level network meta-analysis, the MEDLINE, Embase, and Cochrane databases were systematically searched to identify randomized controlled trials reporting outcomes following intravascular imaging-guided or angiography-guided PCI with drug-eluting stents (DES). OCT, IVUS, and angiography were separately compared as guidance for PCI. Using a frequentist random-effects model network meta-analysis, RRs with corresponding 95% CIs were calculated for each strategy. The primary endpoint was MACE, defined as a composite of cardiac death, myocardial infarction, or target vessel revascularization. RESULTS: Seventeen randomized controlled trials, encompassing 13,751 patients with complex coronary lesions undergoing PCI with DES were incorporated into the analysis. In the network comparison, both OCT (RR: 0.63; 95% CI: 0.55-0.72; P < 0.001) and IVUS (RR: 0.67; 95% CI: 0.56-0.79; P < 0.001) demonstrated superiority over angiography-guided PCI in preventing MACE in complex lesions. These results were consistent in the subgroups of patients with chronic total occlusions, left main coronary artery disease, bifurcation lesions, multivessel coronary artery disease, and moderately or severely calcified lesions. No significant difference in MACE was observed between OCT and IVUS (RR: 0.94; 95% CI: 0.78-1.14; P = 0.52). CONCLUSIONS: In patients with complex coronary lesions undergoing PCI with DES, both OCT-guided PCI and IVUS-guided PCI are more effective at reducing MACE compared with angiography-guided PCI. These findings were consistent across various types of complex coronary lesions and suggest that intravascular imaging-guided PCI should be the preferred approach for this population.
2. Multicenter evaluation of interpretable AI for coronary artery disease diagnosis from PET biomarkers.
An interpretable XGBoost model integrating CAC, perfusion deficits, flow metrics, and functional parameters achieved AUC 0.83 for obstructive CAD, outperforming expert readers and single biomarkers, with consistent performance across demographics and external sites.
Impact: By transparently integrating complementary PET biomarkers and CAC, this multicenter model elevates CAD diagnostic accuracy and scalability, supporting standardized, automated decision support.
Clinical Implications: Clinicians can leverage AI that combines perfusion, flow, and CAC to augment diagnostic accuracy for obstructive CAD, potentially reducing unnecessary angiography and standardizing PET interpretation.
Key Findings
- AI integrating 10 PET/CT-derived parameters achieved AUC 0.83, exceeding physicians (0.80) and single biomarkers (e.g., TPD 0.79, MFR 0.75).
- External validation across three independent sites showed robust and consistent performance across sex, BMI, and age.
- CAC derived from attenuation correction maps augmented perfusion and flow metrics within an interpretable XGBoost framework.
Methodological Strengths
- Large multicenter dataset with independent external validation across three sites
- Interpretable gradient-boosted model integrating multiple complementary imaging biomarkers
Limitations
- Retrospective design limited to patients referred for invasive angiography
- Potential site-specific biases and lack of prospective clinical impact assessment
Future Directions: Prospective, randomized diagnostic-impact studies, inclusion of broader clinical variables, and assessment of downstream outcomes and cost-effectiveness.
Positron emission tomography (PET)/computed tomography (CT) for myocardial perfusion imaging (MPI) provides multiple imaging biomarkers, often evaluated separately. We developed an artificial intelligence (AI) model integrating key clinical PET MPI parameters to improve the diagnosis of obstructive coronary artery disease (CAD). From 17,348 patients undergoing cardiac PET/CT across four sites, 1664 with invasive coronary angiography and no prior CAD were retrospectively analyzed. Coronary artery calcium (CAC) scores were derived from CT attenuation correction maps, and XGBoost model was trained on one site using 10 image-derived parameters: CAC, stress/rest left ventricular ejection fraction, stress myocardial blood flow (MBF), myocardial flow reserve (MFR), ischemic and stress total perfusion deficit (TPD), transient ischemic dilation ratio, rate pressure product, and sex. External validation was performed across three independent sites. In the testing cohort (n = 1278; CAD prevalence 53%), the AI model achieved an area under the receiver operating characteristic curve (AUC) of 0.83 (95% CI: 0.81-0.85), outperforming experienced physicians (0.80, p = 0.02) and individual biomarkers such as ischemic TPD (0.79, p < 0.001) and MFR (0.75, p < 0.001). Performance was consistent across sex, body mass index, and age. AI integrating perfusion, flow, and CAC scoring improves PET MPI diagnostic accuracy, offering automated and interpretable predictions for CAD diagnosis.
3. Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trial.
In a prespecified analysis of a nationwide RCT of 299,881 adults with chronic disease, electronic nudge letters significantly increased influenza vaccination uptake, with particularly strong effects among the 19,481 participants with atrial fibrillation.
Impact: Demonstrates a scalable, low-cost intervention that improves vaccination coverage in a high-risk cardiac population, aligning prevention with public health goals.
Clinical Implications: Health systems can deploy simple electronic letters to increase influenza vaccination among adults with AF under 65, potentially mitigating infection-related cardiovascular complications.
Key Findings
- Among 299,881 randomized participants (18–64 years), 19,481 had AF; vaccination uptake was higher in AF (41.5%) than non-AF (35.8%).
- Electronic nudge letters significantly increased influenza vaccination, with greater relative benefit in participants with AF.
- Prespecified, nationwide RCT design supports generalizability and scalability of the intervention.
Methodological Strengths
- Prespecified analysis within a nationwide randomized controlled trial
- Large sample size with binomial regression assessing effect modification by AF status
Limitations
- Secondary analysis with age restricted to 18–64 years limits extrapolation to older AF populations
- Administrative endpoint without detailed clinical outcomes or blinded assessment
Future Directions: Test tailored messaging content and timing, extend to older AF populations, and evaluate downstream clinical outcomes and cost-effectiveness.
AIMS: Little is known regarding strategies to improve influenza vaccination uptake among individuals with atrial fibrillation (AF). We assessed the effect of electronically delivered behavioural nudges on influenza vaccination uptake and clinical outcomes according to AF status. METHODS AND RESULTS: This is a prespecified analysis of the nationwide randomized NUDGE-FLU-CHRONIC trial in which citizens aged 18-64 years with a chronic disease were randomized to usual care or six different electronic nudge letters aiming to increase influenza vaccination uptake during the 2023-2024 influenza season. The primary endpoint was receipt of an influenza vaccine on or before 1 January 2024. We reported absolute differences and relative risks (RRs) of each intervention letter vs. usual care on influenza vaccination uptake and assessed effect modification by AF status using binomial regression. Among 299 881 randomized participants, 19 481 (6.5%) had a history of AF (median age 58.5 years, 27.8% female). During follow-up, 41.5% of participants with a history of AF received influenza vaccination compared with 35.8% of those without ( CONCLUSION: In this prespecified, secondary analysis, electronic nudge letters highlighting the importance of influenza vaccination were especially effective in increasing influenza vaccination uptake among young and middle-aged adults with AF, supporting simple electronic letters as an efficient public health strategy to improve vaccination coverage in high-risk groups.